Sirolimus-induced acneiform eruption
- PMID: 16286750
- DOI: 10.1159/000088511
Sirolimus-induced acneiform eruption
Abstract
Sirolimus is a new immunosuppressive agent used to prevent rejection in renal allograft recipients in order to reduce the need of potentially nephrotoxic calcineurin inhibitors (cyclosporine, tacrolimus). The cutaneous side effects of sirolimus are not well known and they may have been underestimated. We report 2 cases of follicular acneiform eruptions induced by sirolimus in renal allograft recipients. This dermatologic complication was severe and difficult to treat, and resolved only after discontinuation of sirolimus.
Copyright 2005 S. Karger AG, Basel.
Comment in
-
Kinase inhibitor-induced pustules.Dermatology. 2005;211(4):305-6. doi: 10.1159/000088496. Dermatology. 2005. PMID: 16286735 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
